 | • レポートコード：QYR9ST03210 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、インターベンショナルオンコロジーの世界市場について調査・分析し、インターベンショナルオンコロジーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（放射線療法、アブレーション、粒子塞栓術）、用途別（肝臓癌、肺癌、腎臓癌、骨癌、乳癌、前立腺癌、膵臓癌）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のインターベンショナルオンコロジー市場動向 ・主要企業別マーケットシェア ・インターベンショナルオンコロジーの種類別市場規模2014-2019 （放射線療法、アブレーション、粒子塞栓術） ・インターベンショナルオンコロジーの用途別市場規模2014-2019 （肝臓癌、肺癌、腎臓癌、骨癌、乳癌、前立腺癌、膵臓癌） ・インターベンショナルオンコロジーの北米市場：主要企業・種類別/用途別市場規模 ・インターベンショナルオンコロジーのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・インターベンショナルオンコロジーの中国市場：主要企業・種類別/用途別市場規模 ・インターベンショナルオンコロジーの日本国内市場：主要企業・種類別/用途別市場規模 ・インターベンショナルオンコロジーの東南アジア市場：主要企業・種類別/用途別市場規模 ・インターベンショナルオンコロジーのインド市場：主要企業・種類別/用途別市場規模 ・インターベンショナルオンコロジーの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Boston Scientific、BTG、Medtronic、Merit Medical、Terumo、Accuray、Alpinion Medical Systems、Angiodynamics、Atricure、Baylis Medical、Bovie Medical、Brainlab、Bsd Medical、C. R. Bard、C2 Therapeutics、Cardiofocus、Cook Medical、Eckert And Ziegler Bebig、Edap Tms、Elekta、Galil Medical、Healthtronics、Insightec、Medwaves、Mermaid Medical、Microsulis Medical、Monteris Medical） ・インターベンショナルオンコロジーの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
In 2018, the global Interventional Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Interventional Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Interventional Oncology development in United States, Europe and China.
The key players covered in this study
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Market segment by Type, the product can be split into
Radiation Therapy
Ablation
Particle Embolization
Market segment by Application, split into
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Interventional Oncology status, future forecast, growth opportunity, key market and key players.
To present the Interventional Oncology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Interventional Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Interventional Oncology Market Size Growth Rate by Type (2014-2025)
1.4.2 Radiation Therapy
1.4.3 Ablation
1.4.4 Particle Embolization
1.5 Market by Application
1.5.1 Global Interventional Oncology Market Share by Application (2014-2025)
1.5.2 Liver Cancer
1.5.3 Lung Cancer
1.5.4 Kidney Cancer
1.5.5 Bone Cancer
1.5.6 Breast Cancer
1.5.7 Prostate Cancer
1.5.8 Pancreatic Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Interventional Oncology Market Size
2.2 Interventional Oncology Growth Trends by Regions
2.2.1 Interventional Oncology Market Size by Regions (2014-2025)
2.2.2 Interventional Oncology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Interventional Oncology Market Size by Manufacturers
3.1.1 Global Interventional Oncology Revenue by Manufacturers (2014-2019)
3.1.2 Global Interventional Oncology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Interventional Oncology Key Players Head office and Area Served
3.3 Key Players Interventional Oncology Product/Solution/Service
3.4 Date of Enter into Interventional Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Interventional Oncology Market Size by Type (2014-2019)
4.2 Global Interventional Oncology Market Size by Application (2014-2019)
5 United States
5.1 United States Interventional Oncology Market Size (2014-2019)
5.2 Interventional Oncology Key Players in United States
5.3 United States Interventional Oncology Market Size by Type
5.4 United States Interventional Oncology Market Size by Application
6 Europe
6.1 Europe Interventional Oncology Market Size (2014-2019)
6.2 Interventional Oncology Key Players in Europe
6.3 Europe Interventional Oncology Market Size by Type
6.4 Europe Interventional Oncology Market Size by Application
7 China
7.1 China Interventional Oncology Market Size (2014-2019)
7.2 Interventional Oncology Key Players in China
7.3 China Interventional Oncology Market Size by Type
7.4 China Interventional Oncology Market Size by Application
8 Japan
8.1 Japan Interventional Oncology Market Size (2014-2019)
8.2 Interventional Oncology Key Players in Japan
8.3 Japan Interventional Oncology Market Size by Type
8.4 Japan Interventional Oncology Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Interventional Oncology Market Size (2014-2019)
9.2 Interventional Oncology Key Players in Southeast Asia
9.3 Southeast Asia Interventional Oncology Market Size by Type
9.4 Southeast Asia Interventional Oncology Market Size by Application
10 India
10.1 India Interventional Oncology Market Size (2014-2019)
10.2 Interventional Oncology Key Players in India
10.3 India Interventional Oncology Market Size by Type
10.4 India Interventional Oncology Market Size by Application
11 Central & South America
11.1 Central & South America Interventional Oncology Market Size (2014-2019)
11.2 Interventional Oncology Key Players in Central & South America
11.3 Central & South America Interventional Oncology Market Size by Type
11.4 Central & South America Interventional Oncology Market Size by Application
12 International Players Profiles
12.1 Boston Scientific
12.1.1 Boston Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Interventional Oncology Introduction
12.1.4 Boston Scientific Revenue in Interventional Oncology Business (2014-2019)
12.1.5 Boston Scientific Recent Development
12.2 BTG
12.2.1 BTG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Interventional Oncology Introduction
12.2.4 BTG Revenue in Interventional Oncology Business (2014-2019)
12.2.5 BTG Recent Development
12.3 Medtronic
12.3.1 Medtronic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Interventional Oncology Introduction
12.3.4 Medtronic Revenue in Interventional Oncology Business (2014-2019)
12.3.5 Medtronic Recent Development
12.4 Merit Medical
12.4.1 Merit Medical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Interventional Oncology Introduction
12.4.4 Merit Medical Revenue in Interventional Oncology Business (2014-2019)
12.4.5 Merit Medical Recent Development
12.5 Terumo
12.5.1 Terumo Company Details
12.5.2 Company Description and Business Overview
12.5.3 Interventional Oncology Introduction
12.5.4 Terumo Revenue in Interventional Oncology Business (2014-2019)
12.5.5 Terumo Recent Development
12.6 Accuray
12.6.1 Accuray Company Details
12.6.2 Company Description and Business Overview
12.6.3 Interventional Oncology Introduction
12.6.4 Accuray Revenue in Interventional Oncology Business (2014-2019)
12.6.5 Accuray Recent Development
12.7 Alpinion Medical Systems
12.7.1 Alpinion Medical Systems Company Details
12.7.2 Company Description and Business Overview
12.7.3 Interventional Oncology Introduction
12.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2014-2019)
12.7.5 Alpinion Medical Systems Recent Development
12.8 Angiodynamics
12.8.1 Angiodynamics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Interventional Oncology Introduction
12.8.4 Angiodynamics Revenue in Interventional Oncology Business (2014-2019)
12.8.5 Angiodynamics Recent Development
12.9 Atricure
12.9.1 Atricure Company Details
12.9.2 Company Description and Business Overview
12.9.3 Interventional Oncology Introduction
12.9.4 Atricure Revenue in Interventional Oncology Business (2014-2019)
12.9.5 Atricure Recent Development
12.10 Baylis Medical
12.10.1 Baylis Medical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Interventional Oncology Introduction
12.10.4 Baylis Medical Revenue in Interventional Oncology Business (2014-2019)
12.10.5 Baylis Medical Recent Development
12.11 Bovie Medical
12.12 Brainlab
12.13 Bsd Medical
12.14 C. R. Bard
12.15 C2 Therapeutics
12.16 Cardiofocus
12.17 Cook Medical
12.18 Eckert And Ziegler Bebig
12.19 Edap Tms
12.20 Elekta
12.21 Galil Medical
12.22 Healthtronics
12.23 Insightec
12.24 Medwaves
12.25 Mermaid Medical
12.26 Microsulis Medical
12.27 Monteris Medical
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Interventional Oncology Key Market Segments
Table Key Players Interventional Oncology Covered
Table Global Interventional Oncology Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Interventional Oncology Market Size Market Share by Type 2014-2025
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Ablation Figures
Table Key Players of Ablation
Figure Particle Embolization Figures
Table Key Players of Particle Embolization
Table Global Interventional Oncology Market Size Growth by Application 2014-2025 (Million US$)
Figure Liver Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Kidney Cancer Case Studies
Figure Bone Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Prostate Cancer Case Studies
Figure Pancreatic Cancer Case Studies
Figure Interventional Oncology Report Years Considered
Table Global Interventional Oncology Market Size 2014-2025 (Million US$)
Figure Global Interventional Oncology Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Interventional Oncology Market Size by Regions 2014-2025 (Million US$)
Table Global Interventional Oncology Market Size by Regions 2014-2019 (Million US$)
Table Global Interventional Oncology Market Share by Regions 2014-2019
Figure Global Interventional Oncology Market Share by Regions 2014-2019
Figure Global Interventional Oncology Market Share by Regions 2019
Table Market Top Trends
Table Global Interventional Oncology Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Interventional Oncology Market Share by Manufacturers (2014-2019)
Figure Global Interventional Oncology Market Share by Manufacturers in 2018
Table Global Interventional Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Interventional Oncology Product/Solution/Service
Table Date of Enter into Interventional Oncology Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table Global Interventional Oncology Market Size Share by Type (2014-2019)
Figure Global Interventional Oncology Market Size Market Share by Type (2014-2019)
Table Global Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table Global Interventional Oncology Market Size Share by Application (2014-2019)
Figure Global Interventional Oncology Market Size Market Share by Application (2014-2019)
Figure Global Interventional Oncology Revenue Market Share by Application in 2018
Figure United States Interventional Oncology Market Size 2014-2019 (Million US$)
Table United States Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table United States Key Players Interventional Oncology Market Share (2018-2019)
Table United States Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table United States Interventional Oncology Market Share by Type (2014-2019)
Table United States Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table United States Interventional Oncology Market Share by Application (2014-2019)
Figure Europe Interventional Oncology Market Size 2014-2019 (Million US$)
Table Europe Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table Europe Key Players Interventional Oncology Market Share (2018-2019)
Table Europe Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table Europe Interventional Oncology Market Share by Type (2014-2019)
Table Europe Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table Europe Interventional Oncology Market Share by Application (2014-2019)
Figure China Interventional Oncology Market Size 2014-2019 (Million US$)
Table China Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table China Key Players Interventional Oncology Market Share (2018-2019)
Table China Interventional Oncology Market Size by Type (2014-20189) (Million US$)
Table China Interventional Oncology Market Share by Type (2014-2019)
Table China Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table China Interventional Oncology Market Share by Application (2014-2019)
Figure Japan Interventional Oncology Market Size 2014-2019 (Million US$)
Table Japan Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table Japan Key Players Interventional Oncology Market Share (2018-2019)
Table Japan Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table Japan Interventional Oncology Market Share by Type (2014-2019)
Table Japan Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table Japan Interventional Oncology Market Share by Application (2014-2019)
Figure Southeast Asia Interventional Oncology Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Interventional Oncology Market Share (2018-2019)
Table Southeast Asia Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Interventional Oncology Market Share by Type (2014-2019)
Table Southeast Asia Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Interventional Oncology Market Share by Application (2014-2019)
Figure India Interventional Oncology Market Size 2014-2019 (Million US$)
Table India Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table India Key Players Interventional Oncology Market Share (2018-2019)
Table India Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table India Interventional Oncology Market Share by Type (2014-2019)
Table India Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table India Interventional Oncology Market Share by Application (2014-2019)
Figure Central & South America Interventional Oncology Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Interventional Oncology Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Interventional Oncology Market Share (2018-2019)
Table Central & South America Interventional Oncology Market Size by Type (2014-2019) (Million US$)
Table Central & South America Interventional Oncology Market Share by Type (2014-2019)
Table Central & South America Interventional Oncology Market Size by Application (2014-2019) (Million US$)
Table Central & South America Interventional Oncology Market Share by Application (2014-2019)
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Interventional Oncology Business (2014-2019) (Million US$)
Figure Boston Scientific Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Boston Scientific Recent Development
Table BTG Company Details
Table BTG Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure BTG Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table BTG Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Medtronic Recent Development
Table Merit Medical Company Details
Table Merit Medical Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Merit Medical Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Merit Medical Recent Development
Table Terumo Company Details
Table Terumo Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Terumo Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Terumo Recent Development
Table Accuray Company Details
Table Accuray Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Accuray Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Accuray Recent Development
Table Alpinion Medical Systems Company Details
Table Alpinion Medical Systems Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Alpinion Medical Systems Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Alpinion Medical Systems Recent Development
Table Angiodynamics Company Details
Table Angiodynamics Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Angiodynamics Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Angiodynamics Recent Development
Table Atricure Company Details
Table Atricure Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Atricure Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Atricure Recent Development
Table Baylis Medical Company Details
Table Baylis Medical Revenue in Interventional Oncology Business (2014-2019)(Million US$)
Figure Baylis Medical Revenue Growth Rate in Interventional Oncology Business (2014-2019)
Table Baylis Medical Recent Development
Table Bovie Medical Company Details
Table Brainlab Company Details
Table Bsd Medical Company Details
Table C. R. Bard Company Details
Table C2 Therapeutics Company Details
Table Cardiofocus Company Details
Table Cook Medical Company Details
Table Eckert And Ziegler Bebig Company Details
Table Edap Tms Company Details
Table Elekta Company Details
Table Galil Medical Company Details
Table Healthtronics Company Details
Table Insightec Company Details
Table Medwaves Company Details
Table Mermaid Medical Company Details
Table Microsulis Medical Company Details
Table Monteris Medical Company Details
Table Global Interventional Oncology Market Size by Regions (Million US$) 2019-2025
Figure Global Interventional Oncology Market Size Share by Regions (2019-2025)
Figure Global Interventional Oncology Market Size Share by Regions in 2025
Figure United States Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Europe Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Figure China Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Japan Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Figure India Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Interventional Oncology Market Size Forecast (2019-2025)(Million USD)
Table Global Interventional Oncology Market Size by Product (2019-2025) (Million US$)
Figure Global Interventional Oncology Market Size by Product (2019-2025)
Figure Global Interventional Oncology Market Size by Product in 2025
Table Global Interventional Oncology Market Size by Application (2019-2025) (Million US$)
Figure Global Interventional Oncology Market Size by Application (2019-2025)
Figure Global Interventional Oncology Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ホルモン不応性前立腺癌(HRPCA)の世界市場：市場規模・現状・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …- 前立腺癌の世界市場：市場規模・現状・予測 Prostate cancer is cancer that occurs in the prostate.In 2018, the global Prostate Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Prostate Cancer status, future forecast, grow…
- 膵臓癌治療の世界市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 小細胞肺がん治療薬の世界市場：市場規模・現状・予測 Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 乳がん治療の世界市場：市場規模・現状・予測 Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread …